Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
about
Active surveillance for prostate cancer: when to recommend delayed interventionEvaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.Clinical Utility of Biomarkers in Localized Prostate Cancer.KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approachCCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro.Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancer.Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance?A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience.Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer.A urine-based methylation signature for risk stratification within low-risk prostate cancer.Management of prostate cancer: NYU Case of the Month, July 2017.Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy.[Molecular biomarkers and prognostic factors for prostate cancer].
P2860
Q26801195-F067AABC-EF3D-4770-8AB3-3955E7AE1BBEQ38350249-95FEF0B2-734C-442F-BBF4-E9AEC0208D2FQ38792354-674ABD03-497D-46A5-8C3D-931903355A37Q38849399-13AB0171-9367-42B3-80AE-CDFA95C7CC18Q38960744-C8B167AD-7DD8-405B-AD3E-423A639C4809Q39356200-70070094-2D25-4BBF-995D-0C2A8E9DCA3FQ39387342-E9557515-B22D-4EC9-8B01-028C3B42C8F0Q40467014-8475C7D5-7ECB-4398-95A9-4EC1F28D895EQ40706344-813B2ACE-24EF-409E-897B-C59E27B5B782Q40758146-9A763EBC-1598-410C-9AAB-CB0642BA225FQ41599088-8445D803-85B0-4E11-8D8E-1CD8F9A92351Q42121326-22D390A6-825E-469A-A696-98B8621EAB2DQ50184941-CEA3B8EE-527C-4F8C-906B-5EACEB465F22Q50907465-823111C6-9C2C-4752-BDA1-765E5F23606DQ53251387-FD49B217-557B-4D21-B16C-CFECCF274285
P2860
Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Limited ability of existing no ...... veillance for prostate cancer.
@en
Limited ability of existing no ...... veillance for prostate cancer.
@nl
type
label
Limited ability of existing no ...... veillance for prostate cancer.
@en
Limited ability of existing no ...... veillance for prostate cancer.
@nl
prefLabel
Limited ability of existing no ...... veillance for prostate cancer.
@en
Limited ability of existing no ...... veillance for prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Limited ability of existing no ...... veillance for prostate cancer.
@en
P2093
Janet E Cowan
June M Chan
K Clint Cary
Peter R Carroll
P2860
P304
P356
10.1111/BJU.12554
P577
2014-02-20T00:00:00Z